Cargando…

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers

BACKGROUND: High-level expression of NAD(P)H: quinoneoxidoreductase 1 (NQO1) has been correlated with many types of human cancers, suggesting that NQO1 plays important roles in tumor occurrence and progression. This study attempted to explore the role of NQO1 in tumor progression and prognostic eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhenling, Zhang, Yue, Jin, Tiefeng, Men, Jiguang, Lin, Zhenhua, Qi, Peng, Piao, Yingshi, Yan, Guanghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396547/ https://www.ncbi.nlm.nih.gov/pubmed/25880877 http://dx.doi.org/10.1186/s12885-015-1227-8

Ejemplares similares

NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix
por: Ma, Yue, et al.
Publicado: (2014)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
por: Cui, Xuelian, et al.
Publicado: (2015)

High expression of DEK predicts poor prognosis of gastric adenocarcinoma
por: Piao, Junjie, et al.
Publicado: (2014)

Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer
por: Jin, Tiefeng, et al.
Publicado: (2014)

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
por: Lin, Lijuan, et al.
Publicado: (2013)

Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma
por: Ji, Meiying, et al.
Publicado: (2017)

Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC
por: Piao, Junjie, et al.
Publicado: (2016)

PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer
por: Chen, Liyan, et al.
Publicado: (2017)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation: NQO1/CPT1A promotes PAAD via FAO
por: Xu, Ran, et al.
Publicado: (2023)

Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer
por: Tong, Ying-Hui, et al.
Publicado: (2017)

G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo
por: Zhu, Kun, et al.
Publicado: (2022)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
por: Wang, Kaiyuan, et al.
Publicado: (2019)

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

NQO1 regulates expression and alternative splicing of apoptotic genes associated with Alzheimer's disease in PC12 cells
por: Du, Yingshi, et al.
Publicado: (2023)

Increased NQO1 but Not c-MET and Survivin Expression in Non-Small Cell Lung Carcinoma with KRAS Mutations
por: Yilmaz, Ahmet, et al.
Publicado: (2014)

Curcumol Overcomes TRAIL Resistance of Non‐Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2)
por: Zhang, Jing, et al.
Publicado: (2020)

Flattened microvessel independently predicts poor prognosis of patients with non-small cell lung cancer
por: Fang, Luo, et al.
Publicado: (2017)

Increased Expression of TAP Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer
por: Cheng, Yuanjun, et al.
Publicado: (2020)

High expression of Stabilin-2 predicts poor prognosis in non-small-cell lung cancer
por: Yong, Juanjuan, et al.
Publicado: (2021)

GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
por: Feng, Yong, et al.
Publicado: (2022)

β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers
por: Yang, Yang, et al.
Publicado: (2017)

Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
por: Xu, Jie, et al.
Publicado: (2014)

Construction and validation of a nomogram based on N6‐Methylandenosine‐related lncRNAs for predicting the prognosis of non‐small cell lung cancer patients
por: Xiao, Wenjing, et al.
Publicado: (2022)

High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis
por: He, Chaowen, et al.
Publicado: (2022)

Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer
por: Chen, Jia, et al.
Publicado: (2021)

Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer
por: Liu, Fayong, et al.
Publicado: (2021)

Downregulation of ARID1A is correlated with poor prognosis in non-small cell lung cancer
por: Wang, Tao, et al.
Publicado: (2020)

Clinical implications of high NQO1 expression in breast cancers
por: Yang, Yang, et al.
Publicado: (2014)

SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway
por: Huang, Shanshan, et al.
Publicado: (2022)

Overexpression of Muscarinic Receptor 3 Promotes Metastasis and Predicts Poor Prognosis in Non–Small-Cell Lung Cancer
por: Lin, Gengpeng, et al.
Publicado: (2014)

High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
por: Huang, Minjie, et al.
Publicado: (2015)

MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer
por: Sun, Lichao, et al.
Publicado: (2019)

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019)

Low Expression of Bax Predicts Poor Prognosis in Resected Non-small Cell Lung Cancer Patients with Non-squamous Histology†
por: Jeong, Seong Hyun, et al.
Publicado: (2008)

Redox modulation of NQO1
por: Siegel, David, et al.
Publicado: (2018)

CT radiomics for noninvasively predicting NQO1 expression levels in hepatocellular carcinoma
por: He, Zenglei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_12tle80ah65mn015mq5pojj8n8